Latest total revenue for BIOX: $250M, below the Industrials sector average of $390B.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
The latest total revenue for BIOX is $250M as of June 2026. That compares with $330M in the prior-year period — down 26.1% year over year. That is below the Industrials sector average of $390B. Investors often review this figure alongside Bioceres Crop Solutions's historical trend and sector peers before judging valuation or financial health.
Over the past year, BIOX's total revenue moved from $330M to $250M — a 26.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bioceres Crop Solutions's operating scale or balance-sheet position.
Against Industrials companies, BIOX currently prints $250M for total revenue, while the sector average sits near $390B. That is roughly 99.9% below the sector mean. Large gaps often invite a closer look at Bioceres Crop Solutions's growth, margins, and balance sheet.
A total revenue figure of $250M for BIOX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Industrials average is about $390B. Explore the charts below for those layers of context.
After noting BIOX's total revenue ($250M), review year-over-year change from $330M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.